Scientists find key to miscarriages in blood clotting disorder

November 28, 2017, Monash University
Scientists find key to miscarriages in blood clotting disorder
Prof Harshal Nandurkar and Dr Anushka Samudra are respectively last and first authors on the paper on APS and miscarriage. Credit: Monash University

Monash University researchers have potentially shed light on why women with the rare autoimmune disorder Antiphospholipid syndrome (APS) are prone to successive pregnancy losses.

APS causes abnormal blood clots in the arteries or veins along with the risks that go with clotting, including stroke and Deep Vein Thrombosis. For pregnant women the effects of the disorder can be devastating, causing about half of them to be at risk of sequential miscarriages, spontaneous abortions or premature births.

Now researchers in Monash's Australian Centre for Blood Diseases have identified a that may protect against APS miscarriages. The researchers used purpose-bred injected with the antibodies that cause the condition to test the effects of the proteins CD39 and CD73, which work together to produce a molecule known as adenosine. Adenosine has anti-inflammatory, anti-oxidant and anti-clotting properties.

APS occurs when there is an increased level of circulating antibodies – the proteins designed to attack invading pathogens in the system but which, in the case of autoimmune diseases such as APS, attack the body's own cells. It was known that these antibodies were linked to clotting but not all patients with them go on to have APS; a "second hit" was suspected in triggering the disease.

Dr Maithili Sashindranath, a senior researcher on the paper, which appeared in the Journal of Autoimmunity, said the researchers went in search of this second hit.

"We set out specifically to investigate APS-induced miscarriages," Dr Sashindranath said.

The rates of miscarriages were compared in mice that lacked CD39 and CD73, in , and in mice with large amounts of the two proteins in their blood. The study found, as hypothesised, that mice that lacked CD39 and CD73 both had increased rates of miscarriages. Those with no CD39 lost 20% of fetuses. That is a six-fold increase compared with normal mice which lost 3.67% of foetuses. The mice with no CD73 had a three-fold increase.

Mice with large amounts of CD39 had reduced miscarriage rates compared to those without it.

"Effectively what we were able to show is that the loss of CD39 or CD73 is likely to be the second hit – nothing like this has been shown before," Dr Sashindranath said.

The study lays the foundation for investigations looking at blood samples in women with APS to see if they have reduced levels of CD39/CD73 or antibodies which remove the activities of these proteins, she said.

"Down the track we can look at whether we can deliver CD39 to the affected foetuses using new drugs that we have developed and reduce the rate of for these patients. We will also find out if we would be able to predict why some women with APS go on to develop devastating pregnancy complications and some don't."

Explore further: A human enzyme (CD 39) targets the Achilles heel of sepsis

Related Stories

A human enzyme (CD 39) targets the Achilles heel of sepsis

January 5, 2015
There may never be a way to completely prevent infection, but sepsis may have an Achilles heel that would allow for more effective treatment of the condition. In a new report published in the January 2015 issue of the FASEB ...

Study in mice may reveal insights into causes of miscarriages for some women

August 9, 2017
Researchers at St. Michael's Hospital have identified how natural killer cells in the mouse placenta can cause a fetus to fail to grow in the womb or cause miscarriages.

Researchers describe strategies to decrease immune responses in IBD

November 10, 2015
New research led by scientists at Beth Israel Deaconess Medical Center (BIDMC) helps explain the role of an immunosuppressive pathway associated with inflammatory bowel disease (IBD), a condition that develops in genetically ...

Researchers pinpoint possible new cause for unexplained miscarriages

November 1, 2011
Researchers at St. Michael's Hospital have identified a potential new cause for unexplained miscarriages in mice.

Loss of enzyme promotes tumor progression in endometrial cancer

December 7, 2015
Scientists have shown for the first time why loss of the enzyme CD73 in human cancer promotes tumor progression.

Researchers identify biochemical mechanism behind a rare, painful genetic disease

December 13, 2016
A team of researchers at the National Institutes of Health has uncovered a possible biochemical mechanism behind a rare, painful genetic disorder called ACDC disease, which causes calcium buildup in the arteries. The finding ...

Recommended for you

Quintupling inhaler medication may not prevent asthma attacks in children

March 19, 2018
Children with mild to moderate asthma do not benefit from a common practice of increasing their inhaled steroids at the first signs of an asthma exacerbation, according to clinical trial results published in The New England ...

How allergens trigger asthma attacks

March 19, 2018
A team of Inserm and CNRS researchers from the Institute of Pharmacology and Structural Biology have identified a protein that acts like a sensor detecting allergens in the respiratory tract that are responsible for asthma ...

Single steroid-bronchodilator treatment for control and rescue improves persistent asthma

March 19, 2018
When it comes to treating teens and adults with persistent asthma, using a single corticosteroid and long-acting bronchodilator treatment for both daily asthma control and for rescue relief during sudden asthma attacks is ...

Obesity and health problems: New research on a safeguard mechanism

March 16, 2018
Obesity and its negative impacts on health - including metabolic syndrome, type-2 diabetes mellitus and cardiovascular complications - are a global pandemic (Taubes, 2009). The worldwide incidence of obesity has more than ...

Immune system 'double agent' could be new ally in cancer fight

March 16, 2018
St. Jude Children's Research Hospital scientists have discovered that an enzyme called TAK1 functions like a "double agent" in the innate immune response, serving as an unexpected regulator of inflammation and cell death. ...

Artificial sweetener Splenda could intensify symptoms in those with Crohn's disease

March 15, 2018
In a study that has implications for humans with inflammatory diseases, researchers from Case Western Reserve University School of Medicine and colleagues have found that, given over a six-week period, the artificial sweetener ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.